Overall survival outcomes in MATTERHORN trial support perioperative durvalumab plus chemotherapy as standard of care.

Adding the CDK4/6 inhibitor abemaciclib to endocrine therapy significantly improves overall survival in node-positive, ...

Midwives and family physicians are essential to support mothers facing hypogalactia and maintain WHO-recommended exclusive ...

The European Medicines Agency (EMA) has recommended granting marketing authorization in the EU for brensocatib (Brinsupri, ...

Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.

A large study suggests taking progesterone before pregnancy — not just after conception — may help reduce the risk for ...

Patients with noninfectious intermediate, posterior, or panuveitis requiring immunosuppressive therapy are less likely to ...

Patients with presyncope and those with syncope in the ED have similar 30‑day serious cardiac outcomes, although patients ...

Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...

New draft guidelines on the definition of new active substances don’t apply to deutetrabenazine, the European drug regulator ...

Concomitant use of tramadol and certain antidepressants is associated with a higher risk for seizures among older adults in a ...

The EMA has recommended a first-in-class Bruton’s tyrosine kinase inhibitor to treat immune thrombocytopenia in adults who ...